Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tris Pharma Inc.

www.trispharma.com

Latest From Tris Pharma Inc.

People Round-Up: Dipharma And Xellia North America Get New Heads

Dipharma appoints a new CEO, Xellia gets a new commercial head in North America, promotions are made at Lek, GVK Bio and the APhA, while appointments are seen at Auris Medical and Tris Pharma.

Appointments Strategy

The Post-Shutdown Quality Lowdown

Quality oversight activity began ramping back up after the partial US government shutdown, even as EU oversight activities entered into a Brexit-related slowdown.

Compliance Manufacturing

Deal Watch: Pfizer Offloads Troubled ADHD Products To Manufacturer Tris

Tris acquires Pfizer subsidiary Nextwave, which developed pair of ADHD drugs using Tris delivery technology. Lilly gets oral CGRP candidate from Chugai, while Dova signs US co-promotion partner for Doptelet.

Deals Business Strategies

Bye Bye Vernalis And Another Blow For UK Biotech

Vernalis' decision to switch strategy and enter the US cough-cold market backfired spectacularly and acquirer Ligand is getting hold of what once was a jewel in the UK biotech crown for next to nothing.

M & A Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Tris Pharma Inc.
  • Senior Management
  • Ketan Mehta, Pres. & CEO
    Peter Ciano, CVP, Corp. Dev. & Acting CFO
    Barry Keith Herman, MD, CMO
    Norma Cappetti , SVP, Reg. Affairs
    Nemi Jain, VP, R&D
    Tom Curatolo, Chief Commercial Officer
  • Contact Info
  • Tris Pharma Inc.
    Phone: (732) 940-2800
    2031 US Highway 130
    Monmouth Junction , NJ 08852
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register